129 related articles for article (PubMed ID: 27309376)
1. Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy.
Sun H; Shi M; Zhang W; Zheng YM; Xu YZ; Shi JJ; Liu T; Gunosewoyo H; Pang T; Gao ZB; Yang F; Tang J; Yu LF
J Med Chem; 2016 Jul; 59(13):6329-43. PubMed ID: 27309376
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Pharmacological Evaluation of σ2 Receptor Ligands Based on a 3-Alkoxyisoxazole Scaffold: Potential Antitumor Effects against Osteosarcoma.
Shi JJ; Jia KH; Sun H; Gunosewoyo H; Yang F; Tang J; Luo J; Yu LF
ChemMedChem; 2021 Feb; 16(3):524-536. PubMed ID: 32964625
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel 6,7-dihydro-5H-cyclopenta[d]pyrimidine and 5,6,7,8-tetrahydroquinazoline derivatives as sigma-1 (σ1) receptor antagonists for the treatment of pain.
Lan Y; Songyang Y; Zhang L; Peng Y; Song J
Bioorg Med Chem Lett; 2016 Apr; 26(8):2051-6. PubMed ID: 26947609
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic.
Lan Y; Chen Y; Xu X; Qiu Y; Liu S; Liu X; Liu BF; Zhang G
Eur J Med Chem; 2014 May; 79():216-30. PubMed ID: 24735647
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 2-(3,4-dichlorophenoxy)-N-(2-morpholin-4-ylethyl)acetamide: A selective σ1 receptor ligand with antinociceptive effect.
Navarrete-Vázquez G; Austrich-Olivares A; Godínez-Chaparro B; Hidalgo-Figueroa S; Estrada-Soto S; Hernández-Núñez E; Torres-Gómez H; Schepmann D; Wünsch B
Biomed Pharmacother; 2016 Apr; 79():284-93. PubMed ID: 27044839
[TBL] [Abstract][Full Text] [Related]
6. Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain.
Xiong J; Jin J; Gao L; Hao C; Liu X; Liu BF; Chen Y; Zhang G
Eur J Med Chem; 2020 Apr; 191():112144. PubMed ID: 32087465
[TBL] [Abstract][Full Text] [Related]
7. Development of New Benzylpiperazine Derivatives as σ
Romeo G; Bonanno F; Wilson LL; Arena E; Modica MN; Pittalà V; Salerno L; Prezzavento O; McLaughlin JP; Intagliata S
ACS Chem Neurosci; 2021 Jun; 12(11):2003-2012. PubMed ID: 34019387
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands.
Romeo G; Prezzavento O; Intagliata S; Pittalà V; Modica MN; Marrazzo A; Turnaturi R; Parenti C; Chiechio S; Arena E; Campisi A; Sposito G; Salerno L
Eur J Med Chem; 2019 Jul; 174():226-235. PubMed ID: 31042618
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and metabolic characterisation of the potent sigma1 receptor ligand 1'-benzyl-3-methoxy-3H-spiro[[2]benzofuran-1,4'-piperidine].
Wiese C; Grosse Maestrup E; Schepmann D; Vela JM; Holenz J; Buschmann H; Wünsch B
J Pharm Pharmacol; 2009 May; 61(5):631-40. PubMed ID: 19406002
[TBL] [Abstract][Full Text] [Related]
10. Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring.
Bonifazi A; Del Bello F; Mammoli V; Piergentili A; Petrelli R; Cimarelli C; Pellei M; Schepmann D; Wünsch B; Barocelli E; Bertoni S; Flammini L; Amantini C; Nabissi M; Santoni G; Vistoli G; Quaglia W
J Med Chem; 2015 Nov; 58(21):8601-15. PubMed ID: 26430967
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice.
Cendán CM; Pujalte JM; Portillo-Salido E; Baeyens JM
Psychopharmacology (Berl); 2005 Nov; 182(4):485-93. PubMed ID: 16075285
[TBL] [Abstract][Full Text] [Related]
12. N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system.
Quintão NL; da Silva GF; Antonialli CS; de Campos-Buzzi F; Corrêa R; Filho VC
Anesth Analg; 2010 Mar; 110(3):942-50. PubMed ID: 20185671
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ
Thum S; Schepmann D; Ayet E; Pujol M; Nieto FR; Ametamey SM; Wünsch B
Eur J Med Chem; 2019 Sep; 177():47-62. PubMed ID: 31129453
[TBL] [Abstract][Full Text] [Related]
14. Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418.
Lever JR; Miller DK; Fergason-Cantrell EA; Green CL; Watkinson LD; Carmack TL; Lever SZ
J Pharmacol Exp Ther; 2014 Oct; 351(1):153-63. PubMed ID: 25100754
[TBL] [Abstract][Full Text] [Related]
15. (+)-and (-)-Phenazocine enantiomers: Evaluation of their dual opioid agonist/σ
Prezzavento O; Arena E; Sánchez-Fernández C; Turnaturi R; Parenti C; Marrazzo A; Catalano R; Amata E; Pasquinucci L; Cobos EJ
Eur J Med Chem; 2017 Jan; 125():603-610. PubMed ID: 27721146
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive activity of a synthetic curcuminoid analogue, 2,6-bis-(4-hydroxy-3-methoxybenzylidene)cyclohexanone, on nociception-induced models in mice.
Ming-Tatt L; Khalivulla SI; Akhtar MN; Mohamad AS; Perimal EK; Khalid MH; Akira A; Lajis N; Israf DA; Sulaiman MR
Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):275-82. PubMed ID: 21967232
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain.
Lan Y; Chen Y; Cao X; Zhang J; Wang J; Xu X; Qiu Y; Zhang T; Liu X; Liu BF; Zhang G
J Med Chem; 2014 Dec; 57(24):10404-23. PubMed ID: 25420090
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Biological Evaluation of Sigma-1 (σ
Cao X; Yao Z; Dou F; Zhang Y; Qiu Y; Zhao S; Xu X; Liu X; Liu BF; Chen Y; Zhang G
Chem Biodivers; 2019 Mar; 16(3):e1800599. PubMed ID: 30549193
[TBL] [Abstract][Full Text] [Related]
19. Selective sigma-1 (sigma1) receptor antagonists: emerging target for the treatment of neuropathic pain.
Díaz JL; Zamanillo D; Corbera J; Baeyens JM; Maldonado R; Pericàs MA; Vela JM; Torrens A
Cent Nerv Syst Agents Med Chem; 2009 Sep; 9(3):172-83. PubMed ID: 20021351
[TBL] [Abstract][Full Text] [Related]
20. Predicting the antinociceptive efficacy of σ(1) receptor ligands by a novel receptor fluorescence resonance energy transfer (FRET) based biosensor.
Gómez-Soler M; Fernández-Dueñas V; Portillo-Salido E; Pérez P; Zamanillo D; Vela JM; Burgueño J; Ciruela F
J Med Chem; 2014 Jan; 57(1):238-42. PubMed ID: 24354313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
